A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen

Clinical Trial ID NCT01070290

Rank	Title	Journal	Year	PubWeight™‹?›
1	Targeting the HGF/Met signaling pathway in cancer therapy.	Expert Opin Ther Targets	2012	1.45
2	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33